![]() ActivX Biosciences ActivX Biosciences is a biopharmaceutical company that discovers and develops small molecule drugs. | ![]() Vyripharm Biopharmaceuticals Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases. | ![]() Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | |||
Founding Date | Founding Date 2000 | Founding Date 2019 | Founding Date 1929 | Founding Date 1904 | Founding Date 1935 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Dallas, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 15 | Employees 5 | Employees 5,358 | Employees 7,5692% decrease | Employees 5,8541% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €2.4b (Y, 2021) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit N/A |

Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases.
View company
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company